Key result
AI echocardiography improves patient-specific HF phenotyping, cardiotoxicity prediction, and SCD risk stratification.
Why the study?
Conventional echocardiography relies on population-derived reference values and dichotomous classification schemes that do not fully account for individual patient characteristics or disease complexity.
Design
Review
Supports personalized HF risk stratification in clinic; extends echocardiography toward precision phenotyping and prediction.
Conventional echocardiography traditionally relies on population-derived reference values and dichotomous classification schemes that do not fully account for individual patient characteristics or disease complexity. Artificial intelligence (AI) is driving a paradigm shift toward precision echocardiography by enabling patient-specific cardiovascular assessment through the integration of phenotypic, clinical, and biological data. This review examines how AI is transforming echocardiography from a population-based test into a patient-specific assessment tool that supports precision cardiovascular care. It highlights three clinical applications with potential clinical impact: Heart Failure with Preserved Ejection Fraction phenogrouping for targeted therapy selection, cardio-oncology surveillance with individualized cardiotoxicity risk prediction, and cardiomyopathy risk stratification for personalized sudden cardiac death prevention. For each application, it describes the clinical challenge, the AI-enabled precision solution, and its potential clinical impact. It also outlines a practical roadmap for clinical adoption. Precision echocardiography, powered by AI, holds promise for transforming cardiovascular imaging and diagnostics by enabling more patient-specific assessment, earlier disease detection, and personalized therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Lamia Al Saikhan (2026) studied this question. AI-enabled precision echocardiography advances patient-specific cardiovascular assessment, improving heart failure phenotyping, cardiotoxicity prediction, and sudden death risk stratification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: